DR info

Clinical trials : 18 / Drugs : 15 - (DrugBank : 8) / Drug target genes : 10 - Drug target pathways : 17

Spinal and bulbar muscular atrophy and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
1	Spinal and bulbar muscular atrophy	-
2	Amyotrophic lateral sclerosis	10.000
46	Malignant rheumatoid arthritis	6.469
113	Muscular dystrophy	5.149
86	Pulmonary arterial hypertension	5.047
96	Crohn disease	4.987
6	Parkinson disease	4.978
13	Multiple sclerosis/Neuromyelitis optica	4.955
256	Muscle glycogenosis	4.065
231	Alpha-1-antitrypsin deficiency	4.011
168	Ehlers-Danlos syndrome	3.889
53	Sjogren syndrome	3.862
70	Spinal stenosis	3.818
51	Scleroderma	3.727
10	Charcot-Marie-Tooth disease	3.636
38	Stevens-Johnson syndrome	3.333
114	Non-dystrophic myotonia syndrome	3.194
127	Frontotemporal lobar degeneration	2.812
58	Hypertrophic cardiomyopathy	2.760
140	Dorabe syndrome	2.760
36	Epidermolysis bullosa	2.755
144	Lennox-Gastaut syndrome	2.755
193	Prader-Willi syndrome	2.745
107	Juvenile idiopathic arthritis	2.740
298	Hereditary pancreatitis	2.736
226	Interstitial cystitis with Hunners ulcer	2.695
28	Systemic amyloidosis	2.689
156	Rett syndrome	2.662
84	Sarcoidosis	2.652
8	Huntington disease	2.649
34	Neurofibromatosis	2.644
97	Ulcerative colitis	2.587
3	Spinal muscular atrophy	1.019
111	Congenital myopathy	1.000